Home LiteratureArticle Details
PMID: 19551822 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo.

Journal of medical virology ·Vol. 81 ·No. 8 ·2009-08-00 ·Pages 1403-11

Becerra A, Warke RV, Martin K, Xhaja K, de Bosch N, Rothman AL, Bosch I

Abstract

We used gene expression profiling of human primary cells infected in vitro with dengue virus (DENV) as a tool to identify secreted mediators induced in response to the infection. Affymetrix GeneChip analysis of human primary monocytes, B cells and dendritic cells infected with DENV in vitro showed strong induction of monocyte chemotactic protein 2 (MCP-2/CCL8), interferon gamma-induced protein 10 (IP-10/CXCL10) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/TNFSF10). The expression of these genes was confirmed in dendritic cells infected with DENV in vitro at mRNA and protein levels. A prospectively enrolled cohort of DENV-infected Venezuelan patients was used to measure the levels of these proteins in serum during three different periods of the disease. Results showed significant increase of MCP-2, IP-10, and TRAIL levels in patients infected with DENV during the febrile period, when compared to healthy donors and patients with other febrile illnesses. MCP-2 and IP-10 levels were still elevated during the post-febrile period while TRAIL levels dropped close to normal after defervescense. Patients with primary infections had higher TRAIL levels than patients with secondary infections during the febrile period of the disease. Increased levels of IP-10, TRAIL and MCP-2 in acute DENV infections suggest a role for these mediators in the immune response to the infection. MCP-2 was identified in this work as a new unreported and important dengue-related protein and IP-10 was confirmed as a novel and strong pro-inflammatory marker in acute disease.

MeSH Terms
Adolescent Adult B-Lymphocytes/virology Cells, Cultured Chemokine CCL8/biosynthesis,blood Chemokine CXCL10/biosynthesis,blood Child Cohort Studies Dendritic Cells/virology Dengue/immunology Dengue Virus/immunology,physiology Female Gene Expression Profiling Humans Male Middle Aged Monocytes/virology TNF-Related Apoptosis-Inducing Ligand/biosynthesis,blood Venezuela Young Adult
Chemicals
CCL8 protein, human CXCL10 protein, human Chemokine CCL8 Chemokine CXCL10 TNF-Related Apoptosis-Inducing Ligand TNFSF10 protein, human
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Becerra Aniuska
Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, 01655, USA.
Warke Rajas V
Martin Katherine
Xhaja Kris
de Bosch Norma
Rothman Alan L
Bosch Irene
References (38)
38 references, click to expand
  1. TRAIL is a novel antiviral protein against dengue virus.
    J Virol. 2008 Jan;82(1):555-64 PMID: 17913827
  2. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells.
    J Virol. 2003 Nov;77(21):11822-32 PMID: 14557666
  3. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate.
    J Immunol. 2006 Sep 1;177(5):3185-92 PMID: 16920957
  4. Summaries of Affymetrix GeneChip probe level data.
    Nucleic Acids Res. 2003 Feb 15;31(4):e15 PMID: 12582260
  5. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study.
    Am J Trop Med Hyg. 1990 Feb;42(2):179-84 PMID: 2316788
  6. Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis.
    J Invest Dermatol. 2005 Oct;125(4):746-52 PMID: 16185275
  7. Dengue and dengue haemorrhagic fever: implications of host genetics.
    FEMS Immunol Med Microbiol. 2006 Jul;47(2):155-66 PMID: 16831202
  8. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.
    Gut. 2006 Mar;55(3):374-9 PMID: 16150856
  9. Immunopathogenesis of Dengue hemorrhagic fever.
    Virology. 1999 Apr 25;257(1):1-6 PMID: 10208914
  10. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.
    J Exp Med. 2000 Apr 3;191(7):1095-104 PMID: 10748228
  11. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.
    Yale J Biol Med. 1970 Apr;42(5):311-28 PMID: 5419206
  12. Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation.
    Infect Immun. 2000 Feb;68(2):702-7 PMID: 10639436
  13. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.
    J Clin Microbiol. 1992 Mar;30(3):545-51 PMID: 1372617
  14. Host gene expression profiling of dengue virus infection in cell lines and patients.
    PLoS Negl Trop Dis. 2007 Nov 21;1(2):e86 PMID: 18060089
  15. Infection of human primary hepatocytes with dengue virus serotype 2.
    J Med Virol. 2007 Mar;79(3):300-7 PMID: 17245728
  16. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production.
    Am J Trop Med Hyg. 2000 Jul-Aug;63(1-2):71-5 PMID: 11357999
  17. Elevated levels of soluble ST2 protein in dengue virus infected patients.
    Cytokine. 2008 Feb;41(2):114-20 PMID: 18226917
  18. Early clinical and laboratory indicators of acute dengue illness.
    J Infect Dis. 1997 Aug;176(2):313-21 PMID: 9237695
  19. Safety and antitumor activity of recombinant soluble Apo2 ligand.
    J Clin Invest. 1999 Jul;104(2):155-62 PMID: 10411544
  20. Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation.
    Biochem Biophys Res Commun. 2007 Jun 22;358(1):150-5 PMID: 17467667
  21. Dengue virus selectively induces human mast cell chemokine production.
    J Virol. 2002 Aug;76(16):8408-19 PMID: 12134044
  22. Elevated levels of IL-8 in dengue hemorrhagic fever.
    J Med Virol. 1998 Nov;56(3):280-5 PMID: 9783699
  23. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.
    J Immunol. 2006 Aug 1;177(3):1855-63 PMID: 16849497
  24. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1.
    J Leukoc Biol. 1996 Jan;59(1):67-74 PMID: 8558070
  25. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
    J Infect Dis. 2007 Oct 1;196(7):1053-7 PMID: 17763328
  26. Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide.
    J Virol. 2002 Oct;76(19):9877-87 PMID: 12208965
  27. Joint WHO HQ/SEAROP/WPRO meeting on DengueNet implementation in South-East Asia and the Western Pacific, Kuala Lumpur, 11-13 December 2003.
    Wkly Epidemiol Rec. 2003 Sep 26;78(39):346-7 PMID: 15622835
  28. Macrophage inflammatory protein-1.
    Int J Biochem Cell Biol. 2004 Oct;36(10):1882-6 PMID: 15203102
  29. Dengue: the risk to developed and developing countries.
    Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2395-400 PMID: 8146129
  30. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis.
    J Immunol. 1998 Dec 1;161(11):6338-46 PMID: 9834124
  31. TRAIL-R as a negative regulator of innate immune cell responses.
    Immunity. 2004 Dec;21(6):877-89 PMID: 15589175
  32. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
    Methods. 2001 Dec;25(4):402-8 PMID: 11846609
  33. MIP-1 alpha and MIP-1 beta induction by dengue virus.
    J Med Virol. 2001 Oct;65(2):324-30 PMID: 11536240
  34. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells.
    J Gen Virol. 2006 Dec;87(Pt 12):3623-3630 PMID: 17098977
  35. Mig and IP-10: CXC chemokines that target lymphocytes.
    J Leukoc Biol. 1997 Mar;61(3):246-57 PMID: 9060447
  36. TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release.
    Blood. 2005 May 1;105(9):3413-9 PMID: 15644410
  37. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.
    BMC Infect Dis. 2008 Jun 25;8:86 PMID: 18578883
  38. Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2.
    Mol Immunol. 2007 Mar;44(8):1944-53 PMID: 17081610
Article Info
Journal
Journal of medical virology
Abbr.
J Med Virol
ISSN
1096-9071
Published
2009-08-00
Pages
1403-11
Language
English
Region
United States
NLM ID
7705876
PMCID
PMC2893327
Subset
IM
Grants
NIAID NIH HHS · U01 AI070484-01 · United States
NIAID NIH HHS · U19 AI057319 · United States
NIAID NIH HHS · U19 AI057319-06 · United States
NIAID NIH HHS · U01 AI045440-05 · United States
NIAID NIH HHS · U01 AI070484 · United States
NIAID NIH HHS · U01 AI045440 · United States
NIAID NIH HHS · U01 AI45440 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com